Key facts
- This page summarizes Thomas W. Sweet's Form 4 filing for Medline Inc. (MDLN).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 15 Jun 2026, 17:55.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Award
Additional SEC filing notes
Footnote F1
These securities were acquired in connection with the reclassification of the interests of Medline Holdings, LP prior to the Issuer's initial public offering (as more fully described in the Registration Statement on Form S-1). These securities were previously reported on the Reporting Person's Form 3 filed on December 17, 2025. Represents a grant of restricted stock units ("RSUs") that vest on March 30, 2027.
Footnote F2
These securities are held by Mallard Advisory LLC, of which the Reporting Person is a manager.
Footnote F3
Represents a grant of RSUs that vest on the earlier of (i) the first anniversary of the date of grant, and (ii) the next annual meeting of stockholders following the date of grant.